Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Inverness gets cardiac diagnostics services for $302m

This article was originally published in Clinica

Executive Summary

Inverness Medical Innovations is set to scoop up Alere Medical, a Reno, Nevada-based healthcare service provider to patients suffering from chronic illnesses. The deal, expected to close before the end of 2007, will be worth $302m - a combination of approximately $125m in cash and $177m in Inverness shares. Alere will provide Inverness with a business forecast to generate revenues of $77m in 2007. While offering a range of services in the disease management industry, it specialises particularly in at-home monitoring of chronic heart failure - an aspect that complements the cardiac diagnostics technologies developed by Inverness's Biosite and Stirling Medical subsidiaries.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts